Checks HPV tests after cone biopsy in women with early cervical cancer
Studies whether HPV tests after cone biopsy show leftover tumor in early cervical cancer.
Plain-language title generated from the registry record
Registry title: Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer
Key facts
- Where
- Haifa, IsraelSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT06196190, who can take part
Where in Israel
- Rambam Health Care CenterHaifa, IsraelTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Rambam Health Care Campus
- Trial code
- NCT06196190
- Record updated
- 9 January 2024
- Original description
In women with cervical cancer -Squamous cell carcinoma, Adeno carcinoma,Read full original descriptionShow less
The Prognostic Value of Conization and Negative HPV Typing After Conization Prior to Surgical Intervention in Adenocarcinoma in Situ and Early Stage Cervical Cancer
In women with cervical cancer -Squamous cell carcinoma, Adeno carcinoma,
Adeno-squamous carcinoma or AIS we want to examine prospectively:
1. Examine if negative HR-HPV after conization to the HR-HPV the women had before conization has a high prognostic value for no residual tumor in the final pathology. 2. To examine if conization in women with cervical tumor up to Stage I B 2 (FIGO 2018) is corelated with better prognosis.
Inclusion: Age Range: 18-85 years old Cervical cancer stage I B 2(Tumor up to 4 cm FIGO 2018) AIS HPV types before and after conization.
Exclusion: Pregnant women under 18 years old. Women who refused to continue to be in study. Women that data about HPV types , final pathology or complication are missing.